Dimethaid intends to fill Vioxx void
January 12, 2005 18:35

Pharmaceutical firm says the problems surrounding rivals' pain medications provide it a perfect opportunity After nearly two years of frustration, Dimethaid Research Inc. has a rare opportunity to fill the void left by the recall of arthritis blockbuster... (Read this Vioxx Article)